IceCure Medical
ICCM
12 hedge funds and large institutions have $181K invested in IceCure Medical in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
105% more capital invested
Capital invested by funds: $88.5K → $181K (+$92.8K)
50% more funds holding
Funds holding: 8 → 12 (+4)
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$22.6K |
| 2 |
Barclays
London,
United Kingdom
|
+$21.6K |
| 3 |
SIGI
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
+$19.4K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$16.5K |
| 5 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.99K |
| 2 |
JP Morgan Chase
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $46.4K | – | – | – |
|
2
Bank of America
Charlotte,
North Carolina
| $37.5K | +$5.62K | +157 | +17% |
|
|
3
Renaissance Technologies
New York
| $22K | +$22.6K | +630 | New |
|
|
4
Barclays
London,
United Kingdom
| $21K | +$21.6K | +603 | New |
|
|
SIGI
5
Susquehanna International Group (Ireland)
Dublin,
Ireland
| $18.9K | +$19.4K | +542 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $16K | +$16.5K | +461 | New |
|
|
AWM
7
AE Wealth Management
Topeka,
Kansas
| $11.6K | +$11.9K | +333 | New |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $6.58K | – | – | – |
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
BCWM
10
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $277 | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $104 | +$107 | +3 | New |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$1.99K | -58 | Closed |
|
|
13
JP Morgan Chase
New York
| – | -$1K | -15 | Closed |
|
ICCM Hedge Fund Activity: Q2 2023 in Review
12 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q2 2023, worth a combined $181K — up 105% from $88.5K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ICCM positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $22.6K. The largest seller was UBS Group, exiting entirely with an estimated $1.99K sold.
- 12 institutional investors held IceCure Medical (ICCM) as of Q2 2023, up from 8 in Q1 2023.
- Funds reported $181K of IceCure Medical stock for Q2 2023, up 105% quarter-over-quarter.
- 6 funds opened new IceCure Medical positions in Q2 2023 and 2 closed out, a net change of +4 holders.
- The largest IceCure Medical buyer in Q2 2023 was Renaissance Technologies, an estimated $22.6K added.
- The largest IceCure Medical seller in Q2 2023 was UBS Group, an estimated $1.99K sold.
Based on aggregated 13F filings for Q2 2023.